プレプリント / バージョン1

Can commercial LLMs support regulatory checks in cell processing centers? Evaluation of SOP checking and regulatory question answering using supplied documents

##article.authors##

  • 小林, 徳彦 千葉大学医学部附属病院 https://researchmap.jp/nrkobayashi
  • Yutaro Fuse Department of Artificial Intelligence Medicine, Graduate School of Medicine, Chiba University
  • Hideki Hanaoka Center for Advanced Medicine, Chiba University Hospital
  • Eiryo Kawakami Department of Artificial Intelligence Medicine, Graduate School of Medicine, Chiba University
  • Shinichiro Motohashi Center for Advanced Medicine, Chiba University Hospital

DOI:

https://doi.org/10.51094/jxiv.7094

キーワード:

Large language models、 Cell processing centers、 Regulatory compliance、 Standard operating procedures、 Source grounding、 Human-in-the-loop evaluation

抄録

Introduction

Large language models (LLMs) are increasingly used to retrieve and interpret regulatory information, but their reliability for regulatory compliance checking in cell processing centers (CPCs) remains unclear. This study evaluated commercial LLM platforms on CPC-related regulatory tasks and examined the performance of human and automated evaluators.

Methods

NotebookLM, Gemini, ChatGPT, and Claude answered 72 questions in two tasks involving a model CPC standard operating procedure and Ordinance for Enforcement of the Act on the Safety of Regenerative Medicine. The 288 responses were evaluated using four binary criteria, Answer Accuracy, Citation Fidelity, Citation Precision, and Question Fidelity, and a composite criterion, Practical Compliance (PC), which required all four criteria to be satisfied. A human evaluator, Claude, and NotebookLM independently scored the responses. Automated evaluation was also performed without a reference answer. Discrepant judgments were adjudicated against the source documents, and a workflow in which evaluator disagreement triggered source review was examined retrospectively.

Results

PC differed among the four platforms. Among the 238 responses that satisfied Answer Accuracy, 41 (17.2%) failed at least one of the other three criteria and therefore did not satisfy PC. Citation Fidelity and Citation Precision also differed in a subset of responses, indicating that correct identification of a provision and faithful representation of its content were separate requirements. The human evaluator more often missed defects and rarely over-penalized non-defective responses, whereas the automated evaluators showed both types of error. When a reference answer was provided, the automated evaluators detected more errors overall. A retrospective review strategy focused on cases where the evaluators disagreed narrowed the cases requiring source checking, but some errors were missed by all evaluators.

Conclusions

Satisfying Answer Accuracy alone did not ensure Practical Compliance, and identifying the correct regulatory provision did not ensure faithful representation of its content. Human and automated evaluators showed different patterns of error. Automated evaluation combined with targeted human source review should be evaluated prospectively as a human-in-the-loop approach for CPC practice.

利益相反に関する開示

Declaration of interest: none.

ダウンロード *前日までの集計結果を表示します

ダウンロード実績データは、公開の翌日以降に作成されます。

引用文献

Yokomizo R, Hosoya S, Umezawa A, Okamoto A. Amendment of the Act on the Safety of Regenerative Medicine: a new voyage of regenerative medicine in Japan and the dawn of a new era for young investigators. Regen Ther. 2025;29:237-246. doi:10.1016/j.reth.2025.03.011.

Hosoya S, Ukon Y, Morita K, Minegishi E, Sugihara J, Hasegawa M. Detailed revisions to the subordinate regulation following the amendment of the Act on the Safety of Regenerative Medicine in Japan. Regen Ther. 2025;30:217-223. doi:10.1016/j.reth.2025.06.006.

Ahluwalia K, Abernathy MJ, Algorri M, Cauchon NS, Perico-Norred NM, Albert Youssef RY. The future of regulatory filings: digitalization. AAPS Open. 2025;11:9. doi:10.1186/s41120-025-00113-7.

Ezoe S. Human resources required in the field of regenerative medicine: a follow-up of the Japanese survey in 2015. Regen Ther. 2024;26:541-546. doi:10.1016/j.reth.2024.07.003.

Hassani K. Enhancing legal compliance and regulation analysis with large language models. arXiv:2404.17522 [preprint]. 2024.

Banar N, Lotfi E, Van Nooten J, Kliocaite M, Daelemans W. bLLeQA: benchmarking LLMs for grounded legal question-answering in French and Dutch. In: Proceedings of the 4th Workshop on Towards Knowledgeable Foundation Models. Association for Computational Linguistics; 2026. p. 34-59. doi:10.18653/v1/2026.knowfm-1.4.

European Medicines Agency. Guiding principles on the use of large language models in regulatory science and for medicines regulatory activities. Amsterdam: European Medicines Agency; 2024 Aug 29. https://www.ema.europa.eu/en/documents/other/guiding-principles-use-large-language-models-regulatory-science-medicines-regulatory-activities_en.pdf

Ji Z, Lee N, Frieske R, Yu T, Su D, Xu Y, et al. Survey of hallucination in natural language generation. ACM Comput Surv. 2023;55(12):248. doi:10.1145/3571730.

Ministry of Health, Labour and Welfare. Ordinance for Enforcement of the Act on the Safety of Regenerative Medicine (Ministerial Ordinance No. 110 of 2014) [in Japanese]. Tokyo: MHLW; as amended through October 22, 2025 (MHLW Ordinance No. 103).

https://laws.e-gov.go.jp/law/426M60000100110/20250531_507M60000100015

Kelsall J, Tan X, Bergin A, Chen J, Waheed M, Sorell T, Procter R, Liakata M, Chim J, Chi S. A rapid evidence review of evaluation techniques for large language models in legal use cases: trends, gaps, and recommendations for future research. AI Soc. 2026;41:4025-4043. doi:10.1007/s00146-025-02741-9.

Wallat J, Heuss M, de Rijke M, Anand A. Correctness is not faithfulness in retrieval augmented generation attributions. In: Proceedings of the 2025 International ACM SIGIR Conference on Innovative Concepts and Theories in Information Retrieval. Association for Computing Machinery; 2025. p. 22-32. doi:10.1145/3731120.3744592.

Chen S, Yin H, Zhou S. LegalCiteBench: evaluating citation reliability in legal language models. arXiv:2605.10186 [preprint]. 2026.

Zhou W, Zhang S, Poon H, Chen M. Context-faithful prompting for large language models. In: Findings of the Association for Computational Linguistics: EMNLP 2023. Singapore: Association for Computational Linguistics; 2023. p. 14544-14556. doi:10.18653/v1/2023.findings-emnlp.968.

Onuki Y, Nakamura M. Quantitative and qualitative validation of judgements by large language models in medical education accreditation: Exploratory study towards a Human-in-the-Loop approach [in Japanese]. Medical Education (Japan). 2026;57(3):195–206.

Zheng L, Chiang WL, Sheng Y, Zhuang S, Wu Z, Zhuang Y, et al. Judging LLM-as-a-judge with MT-Bench and Chatbot Arena. Adv Neural Inf Process Syst. 2023;36:46595-46623.

Verga P, Hofstatter S, Althammer S, Su Y, Piktus A, Arkhangorodsky A, et al. Replacing judges with juries: evaluating LLM generations with a panel of diverse models. arXiv:2404.18796 [preprint]. 2024.

Gu J, Jiang X, Shi Z, Tan H, Zhai X, Xu C, et al. A survey on LLM-as-a-judge. Innovation (Camb). 2026;7(6):101253. doi:10.1016/j.xinn.2025.101253.

Krumdick M, Lovering C, Reddy V, Ebner S, Tanner C. No free labels: limitations of LLM-as-a-judge without human grounding. arXiv:2503.05061 [preprint]. 2026.

European Medicines Agency; U.S. Food and Drug Administration. Guiding principles of good AI practice in drug development [Internet]. 2026 Jan 14.

https://www.fda.gov/about-fda/artificial-intelligence-drug-development/guiding-principles-good-ai-practice-drug-development

Panickssery A, Bowman SR, Feng S. LLM evaluators recognize and favor their own generations. Adv Neural Inf Process Syst. 2024;37. doi:10.52202/079017-2197

公開済


投稿日時: 2026-11-06 06:56:15 UTC

公開日時: 2026-11-11 00:28:26 UTC
研究分野
臨床医学